期刊文献+

腹膜透析相关性腹膜炎临床特点与危险因素分析 被引量:30

Clinical characteristics and risk factors of peritoneal dialysis-related peritonitis
在线阅读 下载PDF
导出
摘要 目的探讨腹膜透析相关性腹膜炎发生的原因、特点及相关危险因素,为腹膜炎的防治提供依据。方法回顾性分析2015年6月~2016年12月新乡医学院第一附属医院肾内科规律随访的腹膜透析相关性腹膜炎患者34例,同时收集同期未发生腹膜炎的患者83例,分析腹膜炎发生的原因、特点及危险因素。结果 (1)腹膜炎发生的原因主要是肠道感染12例(35.29%)和换液操作不规范9例(26.47%)。(2)腹透液培养结果显示革兰阳性球菌20例(58.82%),革兰阴性杆菌13例(38.24%),真菌1例(2.94%)。其中革兰阳性菌以表皮葡萄球菌、金黄色葡萄球菌为主,而革兰阴性菌主要以大肠埃希菌为主。革兰阳性球菌对万古霉素、替考拉宁、利奈唑胺敏感,对头孢唑林敏感性70%;革兰阴性杆菌对亚胺培南、美罗培南敏感,对头孢他啶敏感性为80%。(3)多因素logistic回归分析显示,腹膜透析相关性腹膜炎发生的独立危险因素有3个:透析龄[OR=1.106,95%CI(1.027,1.192),P=0.008]、总蛋白水平[OR=20.720,95%CI(1.954,219.728),P=0.012]和血钙水平[OR=113.847,95%CI(9.012,1438.214),P<0.001]。(4)每例患者入院后即给予头孢唑林联合头孢他啶治疗,然后根据药敏结果调整治疗方案,总治愈率为91.18%。结论 (1)本中心腹膜透析相关性腹膜炎发生的主要原因为腹泻和操作不规范;(2)透析龄长、总蛋白和血钙水平降低是腹膜透析相关性腹膜炎发生的独立危险因素;(3)本中心腹膜炎患者多数预后良好,极少数需要拔管才可治愈。 Objective To investigate the causes, characteristics and risk factors of peritoneal dialysis(PD)-related peritonitis. Methods We recruited 34 cases with PD-related peritonitis treated in the First Affiliated Hospital of Xinxiang Medical College from Jun. 2015 to Dec. 2016 as the observation group, and 83 PD cases without peritonitis as the control group. The causes, characteristics and risk factors of peritonitis were analyzed. Results(1) The main causes of peritonitis were intestinal infection(12 cases, 35.29%) and wrong operation of dialysate change(9 cases, 26.47%).(2)The culture of peritoneal fluid found Gram-positive cocci in 20 cases(58.82%), Gram-negative bacilli in 13 cases(38.24%), and fungi in one case(2.94%). Grampositive bacteria were mainly epidermal staphylococcus and staphylococcus aureus, while Gram-negative baclli were mainly E. coli. Gram-positive cocci were sensitive to vancomycin, teicoplanin, and linazolamide in all cases, and the sensitivity rate to cefazolin was 70%. Gram-negative bacteria were sensitive to imipenem and meropenem in all cases, and the sensitivity rate to ceftazidime was 80%.(3) Multivariate logistic regression analysis showed that dialysis duration(OR=1.106, 95% CI 1.027~1.192, P=0.008), plasma protein level(OR=20.720, 95% CI 1.954~219.728, P=0.012) and serum calcium level(OR=113.847, 95% CI 9.012~1438.214, P〈0.001) were the independent risk factors for PD-related peritonitis.(4)cefazolin plus ceftazidime were used as the initial treatment in all cases, and then the therapeutic schedule was adjusted based on the culture results of peritoneal fluid. Thirty-one cases(91.18%) recovered. Conclusions The main causes of PDrelated peritonitis were intestinal infection and wrong operation of dialysate changes. Longer dialysis duration, lower plasma protein and serum calcium were the independent risk factors for PD-related peritonitis.Most patients in our center had a better prognosis, and only a few patients had to take out the Tenkhoff catheter.
出处 《中国血液净化》 2018年第2期73-77,共5页 Chinese Journal of Blood Purification
关键词 腹膜透析相关性腹膜炎 危险因素 Peritoneal dialysis-related peritonitis Risk factors
作者简介 通讯作者:马东红453100,新乡医学院第一附属医院肾病科Email:dhmasxmu@163.com
  • 相关文献

参考文献2

二级参考文献17

  • 1Kim YL. Update on mechanisms of ultrafiltration failure [J]. Perit Dial Int, 2009, 29 (Suppl 2):S123-127.
  • 2Meng XM, Chung AC, Lan HY. Role of the TGF- /BMP-7/ Smad pathways in renal diseases[J]. Clin Sci (Lond), 2013, 124(4):243-254.
  • 3Church RH, Krishnakumar A, Urbanek A, et al. Gremlinl preferentially binds to bone morphogenetic protein- 2 (BMP-2) and BMP-4 over BMP-7[J]. Biochem J, 2015, 466 (1):55-68.
  • 4Marchant V, Droguett A, Valderrama G, et al. Tubular overexpression of Gremlin in transgenic mice aggra- vates renal damage in diabetic ne phropathy[J]. Am J Physiol Renal Physiol, 2015, 309(6):F559-568.
  • 5Tomino Y. Mechanisms and interventions in peritoneal fibrosis[J]. Clin Exp Nephrol, 2012, 16(1):109-114.
  • 6L6pez Cabrera M, Aguilera A, Aroeira LS, et al. Ex vi- vo analysis of dialysis effluent- derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure[J]. Perit Dial Int, 2006, 26(1):26-34.
  • 7Wordinger RJ, Zode G, Clark AF. Focus on molecules: gremlin[J]. Exp Eye Res, 2008, 87(2):78-79.
  • 8Morrissey J, Hruska K, Guo G, et al. Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function[J]. J Am Soc Nephrol, 2002, 13 (Suppl 1):S14-21.
  • 9Wang S, Chen Q, Simon TC, et al. Bone morphogenic pro- tein-7 (BMP-7), a novel therapy for diabetic nephropa-thy[J]. Kidney Int, 2003, 63(6):2037-2049.
  • 10Zeisberg M, Hanai J, Sugimoto H, et al. BMP-7 counter- acts TGF-betal-induced epithelial-to-mesenchymal tran- sition and reverses chronic renal injury[J]. Nat Med, 2003, 9(7):964-968.

共引文献16

同被引文献162

引证文献30

二级引证文献100

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部